References
- Saha S, Chant D, Welham J, McGrath J: A systematic review of the prevalence of schizophrenia. PLoS Med 2005, 2(5):413–433.
- Moskowitz A, Heim G: Eugen Bleuler’s Dementia Praecox or the Group of Schizophrenias (1911): A centenary appreciation and reconsideration. Schizophr Bull 2011, 37(3):471–479.
- Green M.F, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff”? Schizophr Bull 2000, 26(1):119–136.
- Martel JC, Gatti McArthur S: Dopamine receptor subtypes, physiology and pharmacology: new ligands and concepts in schizophrenia. Front Pharmacol 2020, 11(July):1–17.
- Uno Y, Coyle JT: Glutamate hypothesis in schizophrenia. Psychiatry Clin Neurosci 2019, 73(5):204–215.
- Wang P, Li M, Zhao A, Ma J: Application of animal experimental models in the research of schizoph. Am J Med Genet Part B Neuropsychiatr Genet 2021, 186(4):209–227.
- Mouri A, Noda Y, Enomoto T, Nabeshima T: Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment. Neurochem Int. 2007, 51(2-4 spec. iss.):173–184.
- Carmichael O, Lockhart S: Neurotrophins and Brain Imaging Behav Neurosci 2012, (November 2011):289–320.
- Clancy B, Darlington RB, Finlay BL: Translating developmental time across mammalian species. Neuroscience 2001, 105(1):7–17.
- Marenco S, Weinberger DR: The neurodevelopmental hypothesis of schizophrenia: Following a trail of evidence from cradle to grave. Dev Psychopathol 2000, 12(3):501–527.
- Verkhratsky A, Nedergaard M: Physiology of astroglia. Physiol Rev 2018, 98(1):239–389.
- Mahmoud S, Gharagozloo M, Simard C, Gris D: Astrocytes maintain glutamate homeostasis in the cns by controlling the balance between glutamate uptake and release. Cells 2019, 8(2):1–27.
- Mestres-Ventura P, Del Rosario Hernández G: The neuroglia of the rat optic nerve. Part I. Golgi-Hortega and Golgi-EM studies. Eur J Anat 2022, 26(2):167–177.
- Bechtholt-Gompf AJ, Walther HV, Adams MA, Carlezon WA, Ngür D, Cohen BM: Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory. Neuropsychopharmacology 2010, 35(10):2049–2059.
- Haroon E, Miller AH, Sanacora G: Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacology 2017, 42(1):193–215.
- Hajszan T, Leranth C, Roth RH: Subchronic phencyclidine treatment decreases the number of dendritic spine synapses in the rat prefrontal cortex. Biol Psychiatry 2006, 60(6):639–644.
- Stark AK, Uylings HBM, Sanz-Arigita E, Pakkenberg B: Glial cell loss in the anterior cingulate cortex, a subregion of the prefrontal cortex, in subjects with schizophrenia. Am J Psychiatry 2004, 161(5):882–888.
- Ling E, Nemesh J, Goldman M, Kamitaki N, Reed N, Handsaker RE, Genovese G, Vogelgsang JS, Gerges S, Kashin S, Ghosh S, Esposito JM, Morris K, Meyer D, Lutservitz A, Mullally CD, Wysoker A, Spina L, Neumann A, Hogan M, Ichihara K, Berretta S, McCarroll SA: A concerted neuron-astrocyte program declines in ageing and schizophrenia. Nature 2024, 627(8004):604-611.
- Javitt DC: When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol 2009, 5:249–275.
- Ridley RM, Clark BA, Durnford LJ, Baker H: Stimulus-bound perseveration after frontal ablations in marmosets. Neuroscience 1993, 52(3):595–604.
- Hof PR, Morrison JH: The aging brain : morphomolecular senescence of cortical circuits. Trends Neurosci 2004, 27(10):607-613.
- McDougall SA, Moran AE, Baum TJ, Apodaca MG, Real V: Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose. Psychopharmacology (Berl) 2017, 234(18):2683-2696.
- Stojković T, Radonjić NV, Velimirović M, Jevtić G, Popović V, Doknić M, Petronijević ND: Risperidone reverses phencyclidine induced decrease in glutathione levels and alterations of antioxidant defense in rat brain. Prog Neuro-Psychopharmacology Biol Psychiatry 2012, 39(1):192–199.
- Nikolić T, Bogosavljević MV, Stojković T, Kanazir S, Lončarević-Vasiljković N, Radonjić NV, Popić J, Petronijević N: Effects of antipsychotics on the hypothalamus-pituitary-adrenal axis in a phencyclidine animal model of schizophrenia. Cells 2024, 13(17):1425.
- Grayson B, Barnes SA, Markou A, Piercy C, Podda G, Neill JC: Postnatal Phencyclidine (PCP) as a neurodevelopmental animal model of schizophrenia pathophysiology and symptomatology: a review. Curr Top Behav Neurosci 2016, 29:403-428.
- Jones CA, Watson DJ, Fone KC: Animal models of schizophrenia. Br J Pharmacol 2011, 164(4):1162-1194.
- Adams SM, De Rivero Vaccari JC, Corriveau RA: Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J Neurosci 2004, 24(42):9441–9450.
- Cobb JA, O’Neill K, Milner J, Mahajan GJ, Lawrence TJ, May WL, Miguel-Hidalgo J, Rajkowska G, Stockmeier CA: Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder. Neuroscience 2016, 316:209-220.
- Luijerink L, Rodriguez M, Machaalani R: Quantifying GFAP immunohistochemistry in the brain – Introduction of the Reactivity score (R-score) and how it compares to other methodologies. J Neurosci Methods 2024, 402:110025.
- Roksandić D, Radovanović A, Danilović Luković J, Marković D, Kovačević Filipović M, Čolić M: Stereological and immunohistochemical study of the spleen in hypothyroid juvenile rats. Acta Vet Brno 2015, 65(2):246–259.
- Maciejewski PK, Rothman DL: Proposed cycles for functional glutamate trafficking in synaptic neurotransmission. Neurochem Int 2008, 52(4–5):809–825.
- Zhu S, Wang H, Shi R, Zhang R, Wang J, Kong L, Sun Y, He J, Kong J, Wang JF, Li XM: Chronic phencyclidine induces inflammatory responses and activates GSK3β in mice. Neurochem Res 2014, 39(12):2385–2393.
- Roberts GW, Colter N, Lofthouse R, Bogerts B, Zech M, Crow TJ: Gliosis in schizophrenia: A survey. Biol Psychiatry 1986, 21(11):1043–1050.
- Webster MJ, Knable MB, Johnston-Wilson N, Nagata K, Inagaki M, Yolken RH: Immunohistochemical localization of phosphorylated glial fibrillary acidic protein in the prefrontal cortex and hippocampus from patients with schizophrenia, bipolar disorder, and depression. Brain Behav Immun 2001, 15(4):388-400.
- Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP: Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 2016, 21(8):1009-1026.
- Medoff DR, Holcomb HH, Lahti AC, Tamminga CA: Probing the human hippocampus using rCBF: Contrasts in schizophrenia. Hippocampus 2001, 11(5):543–550.
- Kolomeets NS, Uranova N: Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: A post-mortem morphometric study. World J Biol Psychiatry 2010, 11(2 part 2):282–292.
- Townsend L, Pillinger T, Selvaggi P, Veronese M, Turkheimer F, Howes O: Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia. Psychol Med 2023, 53(11):4880-4897.
- de Souza DF, Wartchow KM, Lunardi PS, Brolese G, Tortorelli LS, Batassini C, Biasibetti R, Gonçalves CA: Changes in astroglial markers in a maternal immune activation model of schizophrenia in wistar rats are dependent on sex. Front Cell Neurosci 2015, 9:489.
- Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, Javitt D, Kantrowitz J, Wall MM, Corcoran CM, Schobel SA, Small SA: Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention. Mol Psychiatry 2018, 23(8):1764–1772.
- Sweatt JD: Hippocampal function in cognition. Psychopharmacology (Berl) 2004, 174(1):99–110.
- Kawahata I, Finkelstein DI, Fukunaga K: Dopamine D1–D5 receptors in brain nuclei: implications for health and disease. Receptors 2024, 3(2):155-181.
- Guidolin D, Tortorella C, Marcoli M, Cervetto C, De Caro R, Maura G, Agnati LF: Modulation of neuron and astrocyte dopamine receptors via receptor–receptor interactions. Pharmaceuticals 2023, 16(10):1427.